Darwin Advisors LLC boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 471.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,357 shares of the conglomerate’s stock after purchasing an additional 16,792 shares during the period. Danaher comprises approximately 0.9% of Darwin Advisors LLC’s investment portfolio, making the stock its 24th biggest position. Darwin Advisors LLC’s holdings in Danaher were worth $4,382,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DHR. Provident Wealth Management LLC bought a new stake in Danaher during the third quarter worth $27,000. Howe & Rusling Inc. lifted its stake in shares of Danaher by 81.4% in the 2nd quarter. Howe & Rusling Inc. now owns 156 shares of the conglomerate’s stock valued at $28,000 after acquiring an additional 70 shares during the last quarter. Semmax Financial Advisors Inc. bought a new position in shares of Danaher in the 2nd quarter valued at $35,000. Trustcore Financial Services LLC lifted its stake in shares of Danaher by 36.9% in the 2nd quarter. Trustcore Financial Services LLC now owns 230 shares of the conglomerate’s stock valued at $41,000 after acquiring an additional 62 shares during the last quarter. Finally, Prestige Wealth Management Group LLC lifted its stake in shares of Danaher by 1,055.6% in the 1st quarter. Prestige Wealth Management Group LLC now owns 312 shares of the conglomerate’s stock valued at $43,000 after acquiring an additional 285 shares during the last quarter. Hedge funds and other institutional investors own 78.01% of the company’s stock.
A number of research analysts have recently commented on the company. Wells Fargo & Company reiterated a “buy” rating and issued a $234.00 price target on shares of Danaher in a research note on Tuesday, September 29th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $203.00 price target for the company in a research note on Tuesday, July 21st. Royal Bank of Canada increased their price objective on Danaher from $205.00 to $218.00 and gave the company an “outperform” rating in a report on Friday, July 24th. Jefferies Financial Group increased their price objective on Danaher from $190.00 to $230.00 and gave the company a “buy” rating in a report on Friday, July 24th. Finally, Robert W. Baird increased their price objective on Danaher from $163.00 to $205.00 and gave the company an “outperform” rating in a report on Friday, July 24th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $202.00.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 23rd. The conglomerate reported $1.44 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.09 by $0.35. Danaher had a return on equity of 11.88% and a net margin of 17.73%. The firm had revenue of $5.30 billion during the quarter, compared to the consensus estimate of $5.01 billion. During the same period last year, the business posted $1.09 EPS. The business’s revenue was up 2.7% compared to the same quarter last year. Equities research analysts forecast that Danaher Co. will post 5.48 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, September 28th will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Friday, September 25th. This represents a $0.72 dividend on an annualized basis and a yield of 0.32%. Danaher’s payout ratio is currently 16.29%.
In other news, SVP William King sold 26,982 shares of the stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $199.09, for a total transaction of $5,371,846.38. Following the transaction, the senior vice president now owns 29,821 shares of the company’s stock, valued at approximately $5,937,062.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 77,909 shares of the stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $205.50, for a total transaction of $16,010,299.50. Following the transaction, the senior vice president now directly owns 52,445 shares in the company, valued at approximately $10,777,447.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 530,474 shares of company stock valued at $104,501,669. Company insiders own 11.70% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Why are trading ranges significant?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.